ZA923119B - Pcp receptor ligands and the use thereof - Google Patents

Pcp receptor ligands and the use thereof

Info

Publication number
ZA923119B
ZA923119B ZA923119A ZA923119A ZA923119B ZA 923119 B ZA923119 B ZA 923119B ZA 923119 A ZA923119 A ZA 923119A ZA 923119 A ZA923119 A ZA 923119A ZA 923119 B ZA923119 B ZA 923119B
Authority
ZA
South Africa
Prior art keywords
receptor ligands
pcp receptor
pcp
ligands
receptor
Prior art date
Application number
ZA923119A
Other languages
English (en)
Inventor
Eckard Weber
Weber Eckard
John F W Keana
F W Keana John
Peter Barmettler
Barmettler Peter
Original Assignee
Oregon State
Univ Oregon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State, Univ Oregon filed Critical Oregon State
Publication of ZA923119B publication Critical patent/ZA923119B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA923119A 1991-04-29 1992-04-29 Pcp receptor ligands and the use thereof ZA923119B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69324491A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
ZA923119B true ZA923119B (en) 1993-01-27

Family

ID=24783901

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA923119A ZA923119B (en) 1991-04-29 1992-04-29 Pcp receptor ligands and the use thereof

Country Status (8)

Country Link
EP (1) EP0587670A4 (de)
JP (1) JPH07500571A (de)
AU (1) AU1910792A (de)
CA (1) CA2109420A1 (de)
IE (1) IE921392A1 (de)
PT (1) PT100431B (de)
WO (1) WO1992019621A1 (de)
ZA (1) ZA923119B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508401A (en) * 1991-02-20 1996-04-16 American Home Products Corporation Substituted dibenzo[a,d]cycloheptene NMDA antagonists
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597433A (en) * 1968-08-19 1971-08-03 Ayerst Mckenna & Harrison 10,11 - dihydro - 5,10 - (iminomethano)-5h-dibenzo(a,d)cycloheptene and derivatives thereof
US4940789A (en) * 1989-10-10 1990-07-10 American Home Products Corporation 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents
US5508401A (en) * 1991-02-20 1996-04-16 American Home Products Corporation Substituted dibenzo[a,d]cycloheptene NMDA antagonists

Also Published As

Publication number Publication date
CA2109420A1 (en) 1992-10-30
IE921392A1 (en) 1992-11-04
AU1910792A (en) 1992-12-21
EP0587670A1 (de) 1994-03-23
WO1992019621A1 (en) 1992-11-12
PT100431A (pt) 1993-08-31
PT100431B (pt) 1999-08-31
EP0587670A4 (de) 1995-02-01
JPH07500571A (ja) 1995-01-19

Similar Documents

Publication Publication Date Title
EP0714292A4 (de) Sigma-rezeptor-liganden und ihre verwendung
EP0507863A4 (en) Sigma receptor ligands and the use thereof
GB9127041D0 (en) New use
ZA923119B (en) Pcp receptor ligands and the use thereof
ZA933815B (en) Pyrimidinyl- and triazinyl-salicyl- and -picolyl- amides and the use and preparation thereof.
GB9000241D0 (en) Pharmaceutical use
GB9101503D0 (en) New use
GB9108747D0 (en) New use
GB9121661D0 (en) New use
GB9109060D0 (en) New use
GB9104174D0 (en) New use
GB9104834D0 (en) New use
GB9126476D0 (en) Use
GB9104269D0 (en) New pharmaceutical use
GB9113943D0 (en) New pharmaceutical use
GB9123202D0 (en) New pharmaceutical use
GB9123203D0 (en) New pharmaceutical use
GB9123204D0 (en) New pharmaceutical use
GB9113918D0 (en) New pharmaceutical use
GB9113850D0 (en) New pharmaceutical use
GB9104307D0 (en) New pharmaceutical use
GB9104306D0 (en) New pharmaceutical use
CA69518S (en) Photograph mat
GB9004372D0 (en) New pharmaceutical use
GB9014231D0 (en) New pharmaceutical use